Clinical Trial Details

EORTC-20012

Back to Clinical Trials Database

BEACOPP (4 cycles escalated + 4 cycles baseline) versus ABVD (8 cycles) in stage III & IV Hodgkin's Lymphoma

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 09-Aug-2002
Date Step1 close: 08-Jan-2010
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 550
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/ct/show/NCT00049595
NCT number NCT00049595
EudraCT 2004-001558-10